HomeATRA • NASDAQ
add
Atara Biotherapeutics Inc
Previous close
$12.16
Day range
$11.80 - $12.25
Year range
$5.01 - $18.70
Market cap
85.12M USD
Avg Volume
49.68K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 17.58M | -38.63% |
Operating expense | 12.30M | -70.63% |
Net income | 2.39M | 112.53% |
Net profit margin | 13.58 | 120.42% |
Earnings per share | 0.19 | 106.13% |
EBITDA | 5.62M | 132.98% |
Effective tax rate | 0.13% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 22.32M | -36.75% |
Total assets | 36.90M | -68.54% |
Total liabilities | 71.94M | -68.47% |
Total equity | -35.04M | — |
Shares outstanding | 7.02M | — |
Price to book | -2.42 | — |
Return on assets | 23.85% | — |
Return on capital | -77.37% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 2.39M | 112.53% |
Cash from operations | -7.32M | 31.25% |
Cash from investing | -5.07M | -170.46% |
Cash from financing | 15.30M | 4,823.46% |
Net change in cash | 2.92M | 177.29% |
Free cash flow | -5.38M | -48.01% |
About
Founded
2012
Headquarters
Website
Employees
38
